Bharat Biotech#39;s US partner for Covaxin, Ocugen, faces class action lawsuit

Pomerantz alleges in the class action lawsuit that, the defendants (Ocugen) have made materially false and misleading statements regarding the Company#39;s business, operations, and compliance policies.

from Moneycontrol Business News https://ift.tt/3wQUZ0b